ReviewCancers2022

Landscape of Savolitinib Development for the Treatment of Non-Small Cell Lung Cancer with MET Alteration-A Narrative Review.

Xiaokuan Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.